Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$786M |
| 2 |
Apple
AAPL
|
+$564M |
| 3 |
Amazon
AMZN
|
+$486M |
| 4 |
Meta Platforms (Facebook)
META
|
+$331M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$1.88B |
| 2 |
Alibaba
BABA
|
+$1.21B |
| 3 |
Home Depot
HD
|
+$320M |
| 4 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$274M |
| 5 |
FLIR
FLIR Systems, Inc. (DE) Common Stock
FLIR
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.98% |
| 2 | Financials | 13.87% |
| 3 | Healthcare | 13.39% |
| 4 | Consumer Discretionary | 11.81% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3776
SEACOR Marine Holdings
SMHI
$256M
| $700K | ﹤0.01% |
158,868
+6,802
| +4% | +$30K |
|
3777
Viridian Therapeutics
VRDN
$2.09B
| $700K | ﹤0.01% |
38,283
+15,389
| +67% | +$263K |
|
|
GRTX
3778
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
| $700K | ﹤0.01% |
71,256
-45,010
| -39% | -$366K |
|
|
EPIX
3779
DELISTED
ESSA Pharma
EPIX
| $699K | ﹤0.01% |
24,475
+6,080
| +33% | +$177K |
|
|
BIOR
3780
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
| $698K | ﹤0.01% |
783
-461
| -37% | -$353K |
|
3781
Cocrystal Pharma
COCP
$11.3M
| $697K | ﹤0.01% |
46,528
+17,704
| +61% | +$269K |
|
3782
Weatherford International
WFRD
$6.29B
| $696K | ﹤0.01% |
+38,294
| New | +$655K |
|
3783
Colony Bankcorp
CBAN
$465M
| $693K | ﹤0.01% |
38,807
-46,282
| -54% | -$777K |
|
3784
IRIDEX
IRIX
$14.3M
| $693K | ﹤0.01% |
98,199
+2,383
| +2% | +$18.1K |
|
3785
Inuvo
INUV
$15.1M
| $690K | ﹤0.01% |
71,546
+3,293
| +5% | +$26.4K |
|
3786
ENDRA Life Sciences
NDRA
$5.97M
| $689K | ﹤0.01% |
9
+2
| +29% | +$157K |
|
|
REED
3787
DELISTED
Reeds, Inc. Common Stock
REED
| $687K | ﹤0.01% |
13,484
+2,666
| +25% | +$137K |
|
3788
Altisource Portfolio Solutions
ASPS
$63.6M
| $686K | ﹤0.01% |
9,657
-8,319
| -46% | -$482K |
|
3789
Takeda Pharmaceutical
TAK
$54.6B
| $685K | ﹤0.01% |
40,757
-32,204
| -44% | -$548K |
|
3790
Educational Development Corp
EDUC
$11.8M
| $684K | ﹤0.01% |
54,899
+742
| +1% | +$11.4K |
|
3791
Immunome
IMNM
$2.58B
| $683K | ﹤0.01% |
39,529
-9,802
| -20% | -$217K |
|
|
MRIN
3792
DELISTED
Marin Software
MRIN
| $674K | ﹤0.01% |
10,470
+4,162
| +66% | +$54K |
|
3793
QuickLogic
QUIK
$232M
| $674K | ﹤0.01% |
93,244
+6,468
| +7% | +$42.2K |
|
|
AMBR
3794
Amber International Holding Ltd
AMBR
$130M
| $674K | ﹤0.01% |
6,108
+2,567
| +72% | +$299K |
|
3795
Battalion Oil
BATL
$31.9M
| $673K | ﹤0.01% |
50,255
+3,841
| +8% | +$48.1K |
|
|
OKUR
3796
OnKure Therapeutics
OKUR
$154M
| $672K | ﹤0.01% |
+7,207
| New | +$804K |
|
3797
Everspin Technologies
MRAM
$341M
| $671K | ﹤0.01% |
104,456
+8,630
| +9% | +$49.4K |
|
3798
American Resources Corp
AREC
$191M
| $669K | ﹤0.01% |
262,531
+105,692
| +67% | +$319K |
|
|
RPTX
3799
DELISTED
Repare Therapeutics
RPTX
| $667K | ﹤0.01% |
21,402
| – | – |
|
3800
Dominari Holdings
DOMH
$57.4M
| $666K | ﹤0.01% |
40,944
+4,757
| +13% | +$81.5K |
|
Similar funds
Geode Capital Management's Q2 2021 Portfolio in Review
As of Q2 2021, Geode Capital Management held 4,790 positions worth $726B, up 11% from $654B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Geode Capital Management's Q2 2021 filing shows 331 new, 3,384 increased, 720 reduced and 74 closed positions. Its largest new stake was Organon & Co: 5,070,121 shares worth $153M. The largest sale was Sherwin-Williams, an estimated $1.88B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q2 2021 buy was Organon & Co: 5,070,121 shares worth $153M.
- Geode Capital Management added most to Microsoft in Q2 2021, an estimated $786M increase.
- Geode Capital Management's biggest Q2 2021 reduction was Sherwin-Williams, cutting an estimated $1.88B.
- Geode Capital Management fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $274M.
- Geode Capital Management's ten largest holdings make up 22% of its $726B portfolio in Q2 2021.
- Geode Capital Management opened 331 new positions and closed 74 in Q2 2021.
- Geode Capital Management's portfolio value rose 11% quarter-over-quarter to $726B.
Based on Geode Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.